Clinical Trials Directory

Trials / Unknown

UnknownNCT04075851

The Prevalence of Serum Thyroid Hormone Autoantibodies in Autoimmune Thyroid Diseases

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Shandong Provincial Hospital · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Thyroid hormone autoantibodies(THAA) in serum can Interfere radioimmunoassay for the determination of free thyroid hormones. Thyroid function test plays a key role in the diagnosis and treatment of autoimmune thyroid disease (AITD), and abnormal examination results in misdiagnosis and mistreatment. At present, the epidemiological results of THAA in AITD are inconsistent, and the pathogenesis has not been clarified. However, there is no relevant research on THAA in China. This project intends to collect AITD patients and healthy people, detecting THAA, at the same time testing thyroid function and thyroid autoantibodies, definiting positive rate of THAA in AITD patients, observing the effect of common therapeutic drugs for AITD on THAA, investigating the rule of THAA influencing thyroid function test results .This project will provide the basis and method for how to effectively avoid THAA interfering with thyroid function test.

Conditions

Timeline

Start date
2019-08-01
Primary completion
2022-08-01
Completion
2022-08-01
First posted
2019-09-03
Last updated
2021-04-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04075851. Inclusion in this directory is not an endorsement.

The Prevalence of Serum Thyroid Hormone Autoantibodies in Autoimmune Thyroid Diseases (NCT04075851) · Clinical Trials Directory